For the year ending 2025-12-31, TELO has $7,341,361 in assets. $1,427,991 in debts.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash | 7,286,670 | |||
| Prepaid expenses | 54,691 | |||
| Total current assets | 7,341,361 | |||
| Total assets | 7,341,361 | |||
| Trade accounts payable and accrued liabilities | 536,769 | |||
| Due to officer | 155,518 | |||
| Accrued compensation - officer | 417,470 | |||
| Due to related parties | 318,234 | |||
| Total current liabilities | 1,427,991 | |||
| Total liabilities | 1,427,991 | |||
| Additional paid-in capital | 46,923,433 | |||
| Accumulated deficit | -41,010,063 | |||
| Total stockholders equity | 5,913,370 | |||
| Total liabilities and stockholders equity | 7,341,361 | |||
Telomir Pharmaceuticals, Inc. (TELO)
Telomir Pharmaceuticals, Inc. (TELO)